Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshie Morimoto

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Translational Lung Cancer Research|October 17, 2022
Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective studySayaka Uda, Tadaaki Yamada, Akihiro Yoshimura, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung CancerSatomi Tanaka, Junji Uchino, Takashi Yokoi, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Translational Lung Cancer Research|October 17, 2022
Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective studySayaka Uda, Tadaaki Yamada, Akihiro Yoshimura, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung CancerSatomi Tanaka, Junji Uchino, Takashi Yokoi, et al.
Pageof 4